High-risk germ cell tumors in men high response rate and severe toxicity with cisplatin, vinblastine, bleomycin, and etoposide
- 1 April 1993
- Vol. 71 (7) , 2351-2357
- https://doi.org/10.1002/1097-0142(19930401)71:7<2351::aid-cncr2820710729>3.0.co;2-h
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.Journal of Clinical Oncology, 1990
- High doses of prochlorperazine for cisplatin-induced emesis: A prospective, random, dose–response studyCancer, 1987
- Reactivation of Bleomycin Lung Toxicity following Oxygen AdministrationChest, 1985
- Severe Bleomycin-Induced PneumonitisChest, 1984
- Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimenCancer, 1983
- A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage III testicular cancer with poor prognostic featuresCancer, 1982
- Advanced Extragonadal Germ-Cell TumorsAnnals of Internal Medicine, 1982
- The Role of Maintenance Therapy in Disseminated Testicular CancerNew England Journal of Medicine, 1981
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Bleomycin combination chemotherapy in the management of testicular neoplasiaCancer, 1975